Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Day One Biopharmaceuticals
Biotech
Day One doles out $55M for MabCare’s solid tumor ADC
Day One has inked a $1.2 billion biobucks deal with MabCare Therapeutics for rights to an ADC taking aim at solid tumors in both adults and kids.
Gabrielle Masson
Jun 18, 2024 10:55am
MHRA CEO Raine to depart in Autumn —Chutes & Ladders
Mar 1, 2024 9:30am
Day One jets off with Sprint's VRK1 program for up to $316M
Aug 16, 2023 10:47am
Cerevel swaps CEO—Chutes & Ladders
May 5, 2023 9:30am
Good day for Day One as pediatric brain tumor drug proves worth
Jan 9, 2023 11:43am
Day One spends day 2 hitting up public markets for $150M
Jun 15, 2022 11:16am
